IMPROVEMENTS TO A COMPLEMENTARY FORMULATION FOR COUNTERACTING ADVERSE EFFECTS OF CANCER TREATMENTS AND OF TREATMENTS FOR SOME VIRAL DISEASES

摘要

The invention relates to improvements to a diluted pharmaceutical formulation comprising at least one component of plant, animal and mineral origin, such that said formulation includes Abrotanum as a diluted component of plant origin, Sepia as an diluted component of animal origin, and Phosphorus and Causticum Hahnemanni as diluted components of mineral origin. The formulation is used to counteract and alleviate the adverse effects of radiotherapy, and the adverse effects of treatments using anti-viral medication and/or interferons.